Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Aims: Exercise stress test (EST) represents the gold standard for diagnosis of catecholaminergic polymorphic ventricular tachycardia (CPVT). We aimed to determine the relevance of exercise induced VT for the occurrence of LAE at follow-up.

Methods And Results: In RYR2-related CPVT patients who underwent a baseline EST, we assessed the incidence and severity of ventricular arrhythmias (VA). Data were analysed using logistic regression models and Cox proportional hazards models. The primary outcome was the occurrence of life-threatening arrhythmic event (LAE; composite of sudden cardiac death, aborted cardiac arrest, or hemodynamically non-tolerated VT) at follow-up. In 102 RYR2-related CPVT patients (65 females; median age 16 years, IQR: 11-36 years), exercise-induced VT (bidirectional in 64% of cases) was elicited in 56% patients. VT could not be induced in pre-school children. Lower basal heart rate, early onset VA (within the first step of EST) and heart rate at the first minute of recovery were associated with exercise-induced VT. Cox analyses showed that early onset VA (HR 6.0, 95% CI: 1.3-27.9, P = 0.022) and exercise-induced VT (HR 6.6, 95% CI: 1.5-29.1, P = 0.012) at baseline EST were significantly associated with the occurrence of LAE at follow-up, and remained associated even after correction for symptoms.

Conclusion: Early onset VA and exercise-induced VT at baseline EST was associated with LAE at follow-up, allowing to identify a sub-set of patients at higher risk already at diagnosis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11795671PMC
http://dx.doi.org/10.1093/europace/euae294DOI Listing

Publication Analysis

Top Keywords

ryr2-related cpvt
12
baseline est
12
early onset
12
exercise stress
8
stress test
8
occurrence lae
8
cpvt patients
8
heart rate
8
est associated
8
lae follow-up
8

Similar Publications

RYR2 Variants in Catecholaminergic Polymorphic Ventricular Tachycardia Patients: Insights From Protein Structure and Clinical Data.

Circ Arrhythm Electrophysiol

August 2025

Department of Physiology and Cellular Biophysics, Clyde and Helen Wu Center for Molecular Cardiology, Vagelos College of Physicians and Surgeons, New York, NY (A.C., H.B., L.S., M.C.M., H.D., C.M., S.R., Y.L., Z.D., C.T., S.E., A.R.M.).

Background: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare inherited arrhythmia, with pathogenic variants in the gene responsible for 60% of clinically well-defined CPVT cases. Diagnosis of CPVT often occurs after a major cardiac event, posing a severe threat to the patient's life. A data set of patients with CPVT would improve the diagnosis and treatment of patients with CPVT.

View Article and Find Full Text PDF

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a genetic disorder marked by exercise or stress-induced arrhythmias that lead to syncope or sudden cardiac death. Mutations of the gene can cause either CPVT or calcium release deficiency syndrome, with varying impacts on calcium release in cardiomyocytes. These mutations are predominantly missense variants associated with a gain-of-function mechanism.

View Article and Find Full Text PDF

Aims: Exercise stress test (EST) represents the gold standard for diagnosis of catecholaminergic polymorphic ventricular tachycardia (CPVT). We aimed to determine the relevance of exercise induced VT for the occurrence of LAE at follow-up.

Methods And Results: In RYR2-related CPVT patients who underwent a baseline EST, we assessed the incidence and severity of ventricular arrhythmias (VA).

View Article and Find Full Text PDF
Article Synopsis
  • Cardiac ryanodine receptor (RyR2) mutations can lead to two different conditions: gain-of-function mutations cause catecholaminergic polymorphic ventricular tachycardia (CPVT), while loss-of-function mutations result in calcium release deficiency syndrome (CRDS).
  • A case study of a father and son with the same RyR2 E4107A variant revealed that they exhibited different clinical manifestations, with the son showing signs of long QT syndrome (LQTS) while the father showed symptoms of CPVT.
  • These findings highlight that a single RyR2 variant can lead to diverse symptoms due to the influence of other genetic, epigenetic, or environmental factors, suggesting the need for genetic testing alongside exercise
View Article and Find Full Text PDF

Ryanodine receptor 2 (RyR2) is a large Ca-release channel in the sarcoplasmic reticulum (SR) of cardiac muscle cells. It serves to release Ca from the SR into the cytosol to initiate muscle contraction. RyR2 overactivation is associated with arrhythmogenic cardiac disease, but few specific inhibitors have been reported so far.

View Article and Find Full Text PDF